Whether it’s being applied to tissue engineering, disease modeling, cancer research, drug screening or microphysiological systems(MPS), 3D bioprinting keeps circling back to the same underlying goals: developing models that are more predictive and representative of human biology. This aligns closely to the 3R principles (Replacement, Reduction, Refinement of animal research) and the growing adoption to New Approach Methodologies (NAMs). As a result, researchers are increasingly adopting bioprinting technologies to complement or reduce animal testing.
3D bioprinting as an alternative to animal testing

While animal models remain an important part of biomedical research, they do not fully predict human responses.
Differences between species affects drug efficacy, toxicity, and disease mechanisms. This is where 3D bioprinting can offer a valuable alternative for specific research applications.
By combining human cells with biomaterials and controlled 3D architectures, bioprinted tissues can recreate key aspects of human biology in vitro. These models can be used to study disease mechanisms, evaluate drug responses, and assess toxicity without relying solely on animal models. In some applications, they may help replace animal experiments altogether, while in others, they can complement existing models and reduce the number of animals required.
Importantly, the goal is not simply to replace one model with another. The value of 3D bioprinting lies in generating more human-relevant data and selecting the most appropriate model for each research question. As bioprinting technologies continue to advance, they could therefore become an increasingly important component of NAM-based research and support the implementation of the 3R principles.
Source and reference:
https://pmc.ncbi.nlm.nih.gov/articles/PMC3902221/?utm_source
3D Bioprinting vs. Animal Studies
| Criteria | 3D Bioprinting | Animal Studies |
| Human relevance | Built from human cells, offering more species-relevant testing | Provides whole-organism, systemic data that isolated models can’t yet replicate. |
| Cost & speed | More cost-effective than animal research, with faster iteration. | Higher cost and longer timelines due to breeding and husbandry requirements. |
| Personalization | Can be fully customized to specific patients or disease states. | Limited ability to tailor to individual patient profiles. |
| Role in R&D | Human-relevant 3D tissue models for early-stage discovery, disease modelling, drug screening and toxicity testing.(Replacement & Reduction) | Remains a regulatory and scientific standard for complex, multi-organ interactions. |
Reproducibility with 3D bioprinted tissues
CELLINK’s bioprinting technologies make it possible to fabricate reproducible 3D tissues that better mimic native human physiology. It can provide more relevant data for efficacy, toxicity and disease studies than traditional 2D cell culture models.
Part of what makes 3D bioprinting so versatile is its range: from printing simple spheroid structures, organoids and assembloids to more complex vascularized tissues and organ-on-a-chip systems. That flexibility helps to bridge the gap between conventional in vitro work and in vivo biology, all while supporting research workflows that are more ethical and effective.
Looking ahead, bioprinting is set to play a growing role in both complementing and replacing animal studies, positioning itself as a key direction for pharmaceutical research and research investigations in which a realistic 3D cell environment is essential.
Ready to explore the potential of 3D bioprinting?
Looking to reduce animal studies while advancing more human-relevant research? Our specialists can help you explore how 3D bioprinting can support your research goals, accelerate the adoption of New Approach Methodologies (NAMs), and contribute to the 3Rs through more predictive and reproducible in vitro models.
Are you working in the Benelux or DACH-region?
We are here to help you with all your 3D bioprinting questions. Just reach out to us!



